Johan van Meerloo
Johan van Meerloo publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors and Multiple Myeloma Research and Treatments.
- World rank
- #1,349,045 of 7,710,434 ranked researchers
- Rank in Netherlands
- #30,647 of 107,149
- Works
- 57
- Citations
- 3.7k
- Citations per work
- 65.6
What does Johan van Meerloo research?
Johan van Meerloo's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (33%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2645.0%
- Health Sciences1933.3%
- Medicine1933.3%
- Everything else1221.7%
- 1Molecular Biology41% of their works
- 2Hematology13% of their works
- 3Oncology11% of their works
- 4Infectious Diseases5% of their works
- 5Immunology4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
Which keywords describe Johan van Meerloo's research?
The keywords of their largest research topics: Proteasome Inhibitors, Cancer Therapy, Proteasome, Ubiquitin, Minimal Residual Disease, BET Bromodomains, Prognostic Factors and PROTACs.
- Genomic Aberrations
- SARS-CoV-2
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Tumor Microenvironment
- International Myeloma Working Group
- Prognostic Factors
- BET Bromodomains
- Ubiquitin
- Cancer Therapy
- Proteasome Inhibitors
- Proteasome
- Minimal Residual Disease
- PROTACs
- Diagnosis Criteria
- Fibroblast Activation Protein
- AML
- Acute Myeloid Leukemia
- Coronavirus
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Proteasome Inhibitors352 topics
- Cancer Therapy312 topics
- Proteasome251 topic
- Ubiquitin251 topic
- Minimal Residual Disease152 topics
- BET Bromodomains141 topic
- PROTACs141 topic
- Prognostic Factors143 topics
- Diagnosis Criteria101 topic
- International Myeloma Working Group101 topic
- Fibroblast Activation Protein61 topic
- Tumor Microenvironment61 topic
- AML51 topic
- Acute Lymphoblastic Leukemia51 topic
- Acute Myeloid Leukemia51 topic
- Childhood Cancer51 topic
- Coronavirus51 topic
- SARS-CoV-251 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
Where does Johan van Meerloo work?
Johan van Meerloo's main affiliation in the publication record is Amsterdam UMC Location Vrije Universiteit Amsterdam, Netherlands.
How many publications and citations does Johan van Meerloo have?
OpenAlex counts 57 works and 3,742 citations for Johan van Meerloo, an h-index of 17, ranking #1,349,045 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Johan van Meerloo. Posts are plain text and can be reported.